Cerebroprotein hydrolysate (Harbin Medisan Pharmaceutical)

注射用脑蛋白水解物(哈三联)

Report date: 2025/07/11 17:19:28

Base Information

Drug NameCerebroprotein hydrolysate (Harbin Medisan Pharmaceutical)
Drug Alias Name曲奥
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseBrain Injuries, Traumatic
Global Approved IndicationsAlzheimer DiseaseBrain Injuries, Traumatic
Approved Indications in ChinaAlzheimer DiseaseBrain Injuries, Traumatic
Original Approved Country/TerritoryMainland China
Original Approved Date2005/07/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseBrain Injuries, Traumatic
Inactive IndicationsN/A

Other Information

ATC CodeB05BA04
Related LinksN/A